Abbey Jeffrey D 4
4 · ARGOS THERAPEUTICS INC · Filed Mar 30, 2018
Insider Transaction Report
Form 4
Abbey Jeffrey D
DirectorChief Executive Officer
Transactions
- Award
Common Stock
2018-03-28+67,887→ 93,337 total
Footnotes (1)
- [F1]The shares are subject to a lapsing right of repurchase by the issuer, which shall lapse as to 33,944 shares on June 15, 2018, and with respect to the remaining 33,943 shares on December 14, 2018, subject to the Reporting Person continuing to be an employee of the issuer through each such date.